Regulation of complement factor H in a human liver cell line by interferon-gamma

Area of Science:

• Immunology
• Molecular Biology
• Hepatology

Background:

• Factor H is a key regulator of the alternative complement pathway.
• The liver is the primary site for Factor H synthesis.
• Understanding Factor H regulation is crucial for immune system control.

Purpose of the Study:

• To investigate the regulation of Factor H by interferon-gamma (IFN-gamma) in a human liver cell line.
• To elucidate the molecular mechanisms underlying IFN-gamma-induced Factor H expression.

Main Methods:

• Utilized Hep3b human liver cells as a model system.
• Administered varying concentrations of IFN-gamma and measured Factor H mRNA levels.
• Assessed the role of protein synthesis using cycloheximide (CHX).
• Investigated the involvement of phosphorylation using kinase inhibitors (staurosporine, genistein).

Main Results:

• IFN-gamma significantly increased Factor H mRNA levels, with optimal induction at 50 U/ml.
• Factor H mRNA levels rose within 2 hours, peaking at 24 hours, with a half-life of 3.8 hours.
• Protein synthesis inhibition (CHX) reduced induction by 40%.
• Kinase inhibitors (staurosporine, genistein) markedly inhibited induction (88% and 68%, respectively).
• Complete inhibition was observed with combined CHX and staurosporine treatment.

Conclusions:

• IFN-gamma induces Factor H expression in liver cells through a mechanism dependent on both protein synthesis and phosphorylation.
• The induction likely involves Stat1alpha and a cycloheximide-sensitive protein.
• These findings provide insights into the intricate regulation of complement factor H.